Rebecca Aft

6PUBLICATIONS
105CO-AUTHORS
Cancer diagnosisPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 08, 2024
A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 Study.

Patrick Neven, Nicole Stahl, Maria Vidal

|May 08, 2024
Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models.

Zhanfang Guo, Jingqin Luo, R Jay Mashl

|Apr 04, 2024
Chemotherapy and the Extra-Tumor Immune Microenvironment: EXTRA-TIME.

Tri Giang Phan, Katherine N Weilbaecher, Rebecca Aft

|May 25, 2023
Systemic Alterations in Type-2 Conventional Dendritic Cells Lead to Impaired Tumor Immunity in Pancreatic Cancer.

C Alston James, John M Baer, Chong Zou

|Aug 22, 2019
Gene expression analysis to detect disseminated tumor cells in the bone marrow of triple-negative breast cancer patients predicts metastatic relapse.

Chidananda M Siddappa, Sreeraj G Pillai, Jackie Snider

Pageof 1